Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems

MLA

Bárbara Pinto, et al. “Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems.” Pharmaceutics, vol. 14, no. 6, June 2022, p. 1209. EBSCOhost, https://doi.org/10.3390/pharmaceutics14061209.

APA

Bárbara Pinto, Pedro Novais, Ana C. Henriques, Juliana Carvalho-Tavares, Patrícia M. A. Silva, & Hassan Bousbaa. (2022). Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems. Pharmaceutics, 14(6), 1209. https://doi.org/10.3390/pharmaceutics14061209

Chicago

Bárbara Pinto, Pedro Novais, Ana C. Henriques, Juliana Carvalho-Tavares, Patrícia M. A. Silva, and Hassan Bousbaa. 2022. “Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems.” Pharmaceutics 14 (6): 1209. doi:10.3390/pharmaceutics14061209.